Functional parsing of driver mutations in the colorectal cancer genome reveals numerous suppressors of anchorage-independent growth

Cancer Research

Volumn 71, Issue 13, 2011, Pages 4359-4365

  Eskiocak, Ugur ^a   Kim, Sang Bum ^a   Ly, Peter ^a   Roig, Andres I ^a,b   Biglione, Sebastian ^a   Komurov, Kakajan ^c   Cornelius, Crystal ^a   Wright, Woodring E ^a   White, Michael A ^a   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; PROTEIN P53; SHORT HAIRPIN RNA;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL GROWTH; CELL PROLIFERATION; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE REGULATORY NETWORK; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR GENE; TUMOR SUPPRESSOR GENE;

CELL ADHESION; CELL GROWTH PROCESSES; COLORECTAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; GENES, RAS; GENES, TUMOR SUPPRESSOR; GENOME, HUMAN; HCT116 CELLS; HUMANS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MUTATION; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79959895694     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-0794     Document Type: Article

References (20)

1. Chiarugi P, Giannoni E. Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol 2008;76:1352-64.
2. Kolfschoten IGM, van Leeuwen B, Berns K, Mullenders J, Beijersbergen RL, Bernards R, et al. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 2005;121:849-58. (Pubitemid 40806417)
3. Westbrook TF, Martin ES, Schlabach MR, Leng Y, Liang AC, Feng B, et al. A genetic screen for candidate tumor suppressors identifies REST. Cell 2005;121:837-48. (Pubitemid 40806416)
4. Bric A, Miething C, Bialucha CU, Scuoppo C, Zender L, Krasnitz A, et al. Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. Cancer Cell 2009;16:324-35.
5. Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B, et al. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 2008;135:852-64.
6. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268-74. (Pubitemid 44571966)
7. Ledford H. Big science: the cancer genome challenge. Nature 2010;464:972-4.
8. Carter H, Chen S, Isik L, Tyekucheva S, Velculescu VE, Kinzler KW, et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res 2009;69:6660-7.
9. Youn A, Simon R. Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics 2011;27:175-81.
10. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13. (Pubitemid 350134889)
11. Roig AI, Eskiocak U, Hight SK, Kim SB, Delgado O, Souza RF, et al. Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro. Gastroenterology 2010;138:1012-21.e1-5.
12. Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 2006;66:2116-28.
13. Eskiocak U, Kim SB, Roig AI, Kitten E, Batten K, Cornelius C, et al. CDDO-Me protects against space radiation-induced transformation of human colon epithelial cells. Radiat Res 2010;174:27-36.
14. Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, et al. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell 2000;103:321-30.
15. Hiatt KK, Ingram DA, Zhang Y, Bollag G, Clapp DW. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells. J Biol Chem 2001;276:7240-5.
16. Min J, Zaslavsky A, Fedele G, Mclaughlin SK, Reczek EE, De Raedt T, et al. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factorkappaB. Nat Med 2010;16:286-94.
17. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009;9:537-49.
18. Bode AM, Dong Z. The functional contrariety of JNK. Mol Carcinog 2007;46:591-8. (Pubitemid 47255173)
19. Ventura J-J, Hübner A, Zhang C, Flavell RA, Shokat KM, Davis RJ. Chemical genetic analysis of the time course of signal transduction by JNK. Mol Cell 2006;21:701-10. (Pubitemid 43290736)
20. Soltani MH, Pichardo R, Song Z, Sangha N, Camacho F, Satyamoorthy K, et al. Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma. Am J Pathol 2005;166:1841-50. (Pubitemid 40734406)